Publication
A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
The Lancet. Infectious diseases
Cantaert T, Borand L, Kergoat L, Leng C, Ung S, In S, Peng Y, Phoeun C, Hing C, Taing CN, Saman M, Ong S, Mey C, Choeung R, Ly S, Dussart P, Bourhy H, Tarantola A,